1. Safety and immunogenicity of cell-based quadrivalent influenza vaccine: a randomized trial;Essink;Pediatrics,2022
2. CSL Seqirus
. Seqirus receives FDA approval of its cell-based quadrivalent influenza vaccine, expanding the age indication to include children as young as six months. Available at: https://www.seqirus.us/news/seqirus-receives-fda- approval-for-flucelvax-quadrivalent-for- children-6-months-and-older. Accessed August 18, 2022
3. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies;Belongia;Lancet Infect Dis,2016
4. Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs;Stevens;J Virol,2010
5. Centers for Disease Control and Prevention
. Cell-based flu vaccines. Available at: https://www.cdc.gov/flu/prevent/cell- based.htm. Accessed August 16, 2022